The requested URL was not found on this server.
| Company Name: | TaiMed Biologics, Inc. |
|---|---|
| Stock Name: | TaiMed |
| Market Type: | TPEX-Listed |
| Date Founded: | 2007-09-05 |
| Date of listing: | 2015-11-23 |
| Code: | 4147 |
| Listed Market: | Taipei Exchange |
| Industry: | Biotech |
| Core Business: | new drug development for HIV |
| Chairman: | James Chang |
| Major Shareholder: | Ruentex group, National Development Fund |
| Paid-in Capital: | NT$ 2,523,560,000 |
| Employees: | 70 |
| Stock Transfer Institution: | MasterLink Securities Corporation |
| Auditors: | Deloitte & Touch, Taipei |
| Bankers: | Land Bank of Taiwan, Mega International Commercial Bank, E.Sun Bank |
| Legal Advisors: | Formosan Brothers Attorneys-at-law |
| Address: | 3F., No.607, Ruiguang Rd., Neihu Dist., Taipei City 11492, Taiwan |
| Telephone: | +886-2-2658-0058 |
| Fax: | +886-2-2658-6058 |
| Email: | support@taimedbiologics.com |
| Website: | www.tmb.com.tw |